Advisory Council On The Misuse Of Drugs
Details
A letter from the Minister of State for Crime, Policing and Fire to the Advisory Council on the Misuse of Drugs (ACMD), responding to the ACMDs advice on the use and harms of Cumyl-PeGaClone.
Cumyl-PeGaClone is a synthetic cannabinoid receptor agonist (SCRA), which was added to schedule II of the Convention on Psychotropic Substances of 1971 during the 64th Commission on Narcotic Drugs (CND) meeting in April 2021.
In 2022, the government commissioned the ACMD to give advice on the appropriate classification and scheduling of Cumyl-PeGaClone under the Misuse of Drugs Act 1971, to which they responded with their report in May 2023.